Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Saints1976on Dec 23, 2017 5:03pm

109 Views

Post# 27222546

RE:News just out about issuing MORE shares...?

if all options, issued from this month, are exercised that would give the company roughly $2.8 million in the bank. Add their money left over from the sale of the Washington property that gives them almost $4 million in the bank. Well who seems ready to buy a L.P. in Canada!!!!! Looking forward to 2018. Glta Saints

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments